Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast-enhanced ultrasonography: Preliminary result

The present study aimed to determine the usefulness of contrast-enhanced ultrasonography (CEUS) with Sonazoid in evaluating the therapeutic response to sorafenib for hepatocellular carcinoma (HCC). In total, 26 patients with advanced HCC who received sorafenib and were followed up by CEUS were enrol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: SHIOZAWA, KAZUE, WATANABE, MANABU, IKEHARA, TAKASHI, KOGAME, MICHIO, KIKUCHI, YOSHINORI, IGARASHI, YOSHINORI, SUMINO, YASUKIYO
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4907316/
https://ncbi.nlm.nih.gov/pubmed/27347183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4669
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars